<--- Back to Details
First PageDocument Content
Oncology / Organofluorides / Medullary thyroid cancer / Cabozantinib / Vandetanib / Thyroid neoplasm / Multiple endocrine neoplasia / End point of clinical trials / Metastasis / Medicine / Thyroid cancer / Chemistry
Oncology
Organofluorides
Medullary thyroid cancer
Cabozantinib
Vandetanib
Thyroid neoplasm
Multiple endocrine neoplasia
End point of clinical trials
Metastasis
Medicine
Thyroid cancer
Chemistry

cabozantinib 20mg and 80mg hard capsules (Cometriq®) Swedish Orphan Biovitrum Ltd. SMC No[removed]February 2015

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Download Document from Source Website

File Size: 199,18 KB

Share Document on Facebook

Similar Documents

1. World J SurgJul 11. [Epub ahead of print] Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. Kluijfhout WP(1,)(2), Beninato T(3), Drake FT(3), Vr

1. World J SurgJul 11. [Epub ahead of print] Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. Kluijfhout WP(1,)(2), Beninato T(3), Drake FT(3), Vr

DocID: 1qGKw - View Document

Hopeline Mission Statement Hope for Two... The Pregnant with

Hopeline Mission Statement Hope for Two... The Pregnant with

DocID: 1preA - View Document

Guidelines for the management of thyroid cancer

Guidelines for the management of thyroid cancer

DocID: 1p6tG - View Document

®  Thyroid Surgery What is the thyroid gland?  FAQ

® Thyroid Surgery What is the thyroid gland? FAQ

DocID: 1g9n7 - View Document

®  Thyroid Nodules What is the thyroid gland?  FAQ

® Thyroid Nodules What is the thyroid gland? FAQ

DocID: 1fWdW - View Document